Given the important role of immunotherapy in HCC, we analysed the correlation between the ZNF529-AS1 expression level and the pathway enrichment scores predicted by immunotherapy as well as key steps of the cancer-immunity cycle (Fig. 8C, D). This evidence concerns the gene ZNF529 and cancer.